Showing results (21-30 of 1,073) with videos related to
Sort By:
Pageof 108
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 22, 2016
[Progressions on Diagnosis and Treatment of Ground-glass Opacity]Yue Zhao, Rui Wang, Haiquan ChenOncotargets and Therapy|February 27, 2016
Effect of tumor size on prognosis of node-negative lung cancer with sufficient lymph node examination and no disease extensionYang Zhang, Yihua Sun, Haiquan ChenThe Annals of Thoracic Surgery|June 12, 2020
Management of Ground-Glass Opacities in the Lung Cancer SpectrumYang Zhang, Fangqiu Fu, Haiquan ChenThe Lancet Regional Health. Western Pacific|May 29, 2026
LDCT screening for lung cancer in East Asian never-smokers: balancing benefits and overdiagnosis-related harmsXuan Xu, Haiquan Chen, Wanghong XuFrontiers in Public Health|May 7, 2026
Digital and offline social participation configurations and depressive symptoms and life satisfaction among older adults in ChinaLizhen Wei, Yu Tian, Haiquan ChenJournal of Cancer Research and Clinical Oncology|June 9, 2019
A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapyHan Han, Yue Zhao, Zhendong Gao, et al.Translational Lung Cancer Research|December 13, 2023
Residual tumor descriptors proposed by the International Association for the Study of Lung Cancer may not be applicable to stage I and ground-glass opacity-featured non-small cell lung cancerZhexu Wen, Fangqiu Fu, Yue Zhao, et al.Translational Lung Cancer Research|August 25, 2021
Systemic immune-inflammation index is a stage-dependent prognostic factor in patients with operable non-small cell lung cancerFangqiu Fu, Chaoqiang Deng, Zhexu Wen, et al.The Journal of Thoracic and Cardiovascular Surgery|March 25, 2024
Prognostic value of KRAS G12V mutation in lung adenocarcinoma stratified by stages and radiological featuresWangyang Zhu, Han Han, Zelin Ma, et al.Seminars in Thoracic and Cardiovascular Surgery|January 14, 2021
Surgical Strategies for Pre- and Minimally Invasive Lung Adenocarcinoma 3.0: Lessons Learned From the Optimal Timing of Surgical InterventionYang Zhang, Zongwei Chen, Hong Hu, et al.Pageof 108